Accueil > Actualité
Actualite financiere : Actualite bourse

AstraZeneca: gets EU approval for pancreatic cancer drug

(CercleFinance.com) - AstraZeneca said on Wednesday that a cancer drug it has developed with Merck has been approved in Europe for metastatic pancreatic cancer.


The drugmaker said that Lynparza has been approved by the European Commission for patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer.

Pancreatic cancer is a rare, life-threatening disease with the lowest survival rate amongst the most common cancers. About 5%-7% of patients with metastatic pancreatic cancer have a germline BRCA mutation.

Copyright (c) 2020 CercleFinance.com. All rights reserved.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.